Functional evaluation of PDGFB-variants in idiopathic basal ganglia calcification, using patient-derived iPS cells

[1]  H. Sarva,et al.  Primary Familial Brain Calcification , 2020, The Journal of the American Osteopathic Association.

[2]  D. Geschwind,et al.  Primary brain calcification: an international study reporting novel variants and associated phenotypes , 2018, European Journal of Human Genetics.

[3]  D. Geschwind,et al.  Primary brain calcification: an international study reporting novel variants and associated phenotypes , 2018, European Journal of Human Genetics.

[4]  Z. Xiong,et al.  Biallelic Mutations in MYORG Cause Autosomal Recessive Primary Familial Brain Calcification , 2018, Neuron.

[5]  Y. Hayashi,et al.  Inorganic phosphorus (Pi) in CSF is a biomarker for SLC20A2-associated idiopathic basal ganglia calcification (IBGC1) , 2018, Journal of the Neurological Sciences.

[6]  J. Lupski,et al.  Phenotype expansion and development in Kosaki overgrowth syndrome , 2018, Clinical genetics.

[7]  Cristina Has,et al.  Faculty of 1000 evaluation for Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. , 2018 .

[8]  M. Inden,et al.  Induced pluripotent stem cells derived from a patient with familial idiopathic basal ganglia calcification (IBGC) caused by a mutation in SLC20A2 gene. , 2017, Stem cell research.

[9]  T. Kawanami,et al.  Clinical and radiological diversity in genetically confirmed primary familial brain calcification , 2017, Scientific Reports.

[10]  T. Griffin,et al.  STAT1 modulates tissue wasting or overgrowth downstream from PDGFRβ , 2017, Genes & development.

[11]  M. Inden,et al.  Neuroprotective effect of 5-aminolevulinic acid against low inorganic phosphate in neuroblastoma SH-SY5Y cells , 2017, Scientific Reports.

[12]  K. Kosaki,et al.  Expansion of the phenotype of Kosaki overgrowth syndrome , 2017, American journal of medical genetics. Part A.

[13]  Matthew S. Lebo,et al.  Performance of ACMG-AMP Variant-Interpretation Guidelines among Nine Laboratories in the Clinical Sequencing Exploratory Research Consortium. , 2016, American journal of human genetics.

[14]  S. Yamanaka,et al.  Enhanced engraftment, proliferation, and therapeutic potential in heart using optimized human iPSC-derived cardiomyocytes , 2016, Scientific Reports.

[15]  S. Hornemann,et al.  Functional Characterization of Germline Mutations in PDGFB and PDGFRB in Primary Familial Brain Calcification , 2015, PloS one.

[16]  D. Geschwind,et al.  Brain calcification process and phenotypes according to age and sex: Lessons from SLC20A2, PDGFB, and PDGFRB mutation carriers , 2015, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[17]  Julie C. Sapp,et al.  A Point Mutation in PDGFRB Causes Autosomal-Dominant Penttinen Syndrome. , 2015, American journal of human genetics.

[18]  D. Geschwind,et al.  Mutations in XPR1 cause primary familial brain calcification associated with altered phosphate export , 2015, Nature Genetics.

[19]  Bale,et al.  Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.

[20]  G. Coppola,et al.  First Japanese family with primary familial brain calcification due to a mutation in the PDGFB gene: An exome analysis study , 2015, Psychiatry and clinical neurosciences.

[21]  H. Okano,et al.  Novel overgrowth syndrome phenotype due to recurrent de novo PDGFRB mutation. , 2015, The Journal of pediatrics.

[22]  M. Sobrido,et al.  Primary familial brain calcifications. , 2014, Handbook of clinical neurology.

[23]  J. R. Oliveira,et al.  First Report of a De Novo Mutation at SLC20A2 in a Patient with Brain Calcification , 2014, Journal of Molecular Neuroscience.

[24]  O. Martinaud,et al.  PDGFB Partial Deletion: a New, Rare Mechanism Causing Brain Calcification with Leukoencephalopathy , 2014, Journal of Molecular Neuroscience.

[25]  D. Dickson,et al.  SLC20A2 and THAP1 deletion in familial basal ganglia calcification with dystonia , 2014, neurogenetics.

[26]  Kortaro Tanaka,et al.  Evaluation of SLC20A2 mutations that cause idiopathic basal ganglia calcification in Japan , 2014, Neurology.

[27]  Y. Béjot,et al.  A de novo nonsense PDGFB mutation causing idiopathic basal ganglia calcification with laryngeal dystonia , 2014, European Journal of Human Genetics.

[28]  R. Ransohoff,et al.  Development, maintenance and disruption of the blood-brain barrier , 2013, Nature Medicine.

[29]  L. Defebvre,et al.  Phenotypic spectrum of probable and genetically-confirmed idiopathic basal ganglia calcification. , 2013, Brain : a journal of neurology.

[30]  Jw Lee.  Mutations in PDGFRB and NOTCH3 are the first genetic causes identified for autosomal dominant infantile myofibromatosis , 2013, Clinical genetics.

[31]  D. Geschwind,et al.  Mutations in the gene encoding PDGF-B cause brain calcifications in humans and mice , 2013, Nature Genetics.

[32]  M. Sasahara,et al.  The Roles of PDGF in Development and During Neurogenesis in the Normal and Diseased Nervous System , 2013, Journal of Neuroimmune Pharmacology.

[33]  Yiran Guo,et al.  Mutations in PDGFRB cause autosomal-dominant infantile myofibromatosis. , 2013, American journal of human genetics.

[34]  W. Chung,et al.  A recurrent PDGFRB mutation causes familial infantile myofibromatosis. , 2013, American journal of human genetics.

[35]  S. Yamanaka,et al.  An Efficient Nonviral Method to Generate Integration‐Free Human‐Induced Pluripotent Stem Cells from Cord Blood and Peripheral Blood Cells , 2013, Stem cells.

[36]  L. Defebvre,et al.  Mutation of the PDGFRB gene as a cause of idiopathic basal ganglia calcification , 2013, Neurology.

[37]  Mugen Liu,et al.  Mutations in SLC20A2 link familial idiopathic basal ganglia calcification with phosphate homeostasis , 2012, Nature Genetics.

[38]  C. Betsholtz,et al.  Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. , 2011, Developmental cell.

[39]  Bengt R. Johansson,et al.  Pericytes regulate the blood–brain barrier , 2010, Nature.

[40]  B. Barres,et al.  Pericytes are required for blood–brain barrier integrity during embryogenesis , 2010, Nature.

[41]  Berislav V. Zlokovic,et al.  Pericytes Control Key Neurovascular Functions and Neuronal Phenotype in the Adult Brain and during Brain Aging , 2010, Neuron.

[42]  Johanna Andrae,et al.  Role of platelet-derived growth factors in physiology and medicine. , 2008, Genes & development.

[43]  B. Manyam.  What is and what is not 'Fahr's disease'. , 2005, Parkinsonism & related disorders.

[44]  Y. Oiso,et al.  Stimulation of Na-dependent phosphate transport by platelet-derived growth factor in rat aortic smooth muscle cells. , 2004, Atherosclerosis.

[45]  U. Landegren,et al.  Endothelial PDGF-B retention is required for proper investment of pericytes in the microvessel wall. , 2003, Genes & development.

[46]  Matthew S. Lebo,et al.  Performance of ACMG-AMP Variant-Interpretation Guidelines among Nine Laboratories in the Clinical Sequencing Exploratory Research Consortium. , 2016, American journal of human genetics.